<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Lancet Respir Med</span><span class="iso-abbrev" title="iso-abbrev">Lancet Respir Med</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">The Lancet. Respiratory Medicine</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">2213-2600</span><span class="issn-epub" tagx="issn" title="issn-epub">2213-2619</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Elsevier Ltd.</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7398675">7398675</a></span><span class="publisher-id" title="publisher-id">S2213-2600(20)30311-8</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1016/S2213-2600(20)30311-8">10.1016/S2213-2600(20)30311-8</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Article</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
How COVID-19 could benefit tuberculosis and HIV services in South Africa</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Keene</span><span class="given-names" tagx="given-names" title="given-names">Claire</span></span><a href="#aff1">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mohr-Holland</span><span class="given-names" tagx="given-names" title="given-names">Erika</span></span><a href="#aff1">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cassidy</span><span class="given-names" tagx="given-names" title="given-names">Tali</span></span><a href="#aff1">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Scott</span><span class="given-names" tagx="given-names" title="given-names">Vera</span></span><a href="#aff2">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nelson</span><span class="given-names" tagx="given-names" title="given-names">Aurelie</span></span><a href="#aff3">c</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Furin</span><span class="given-names" tagx="given-names" title="given-names">Jennifer</span></span><a href="#aff4">d</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">TriviÃ±o-Duran</span><span class="given-names" tagx="given-names" title="given-names">Laura</span></span><a href="#aff3">c</a></span><span class="citation_author_institution" id="aff1">[a], </span><span class="citation_author_institution" id="aff2">[b], </span><span class="citation_author_institution" id="aff3">[c], </span><span class="citation_author_institution" id="aff4">[d], </span></div><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2020-8-8</span></span><span class="pub-date-ppub" title="pub-date-ppub">ppub: <span>2020-9</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2020-8-8</span></span><span class="volume" tagx="volume" title="volume">8</span><span class="issue" tagx="issue" title="issue">9</span><span class="fpage" tagx="fpage" title="fpage">844</span><span class="lpage" tagx="lpage" title="lpage">846</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Elsevier Ltd</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.</span></span></div> </div> </div> <div class="body" title="body"> <p id="para410">At the time of writing, more than 17 million people have contracted COVID-19 globally and more than half a million have died.<a href="#bib1"><sup>1</sup></a> However, the health impact of COVID-19 is likely to be far more substantial and long-lasting in countries with high incidences of tuberculosis and HIV<a href="#bib2"><sup>2</sup></a> than in those with low incidences. Tuberculosis and HIV each have more than double the mortality rate of COVID-19, as shown in the Western Cape, South Africa.<a href="#bib3"><sup>3</sup></a></p> <p id="para420">The biological interactions between tuberculosis, HIV, and COVID-19, as well as health system factors contribute to the impact of COVID-19 on vulnerable populations. Modelling data show that COVID-19 could trigger an excess of 6 million tuberculosis deaths by 2025, with decreased diagnosis, treatment initiation, and successful treatment completion.<a href="#bib4"><sup>4</sup></a> Similarly, a 6-month disruption in antiretroviral therapy (ART) delivery for HIV could result in up to half a million additional deaths, double mother-to-child transmission in sub-Saharan Africa over one year, and increase mortality by up to 40% over the next 5 years.<a href="#bib5"><sup>5</sup></a> In addition, disrupted drug supplies could lead to drug resistance, amplifying the costs of managing these entrenched epidemics. Although modelling has limitations, COVID-19 will no doubt have a lasting negative impact on both diseases.</p> <p id="para430">South Africa has had remarkable successes in the management of HIV and tuberculosis in the past 10 years,<a href="#bib6"><sup>6</sup></a> but these gains are threatened by COVID-19. MÃ©decins Sans FrontiÃ¨res has collaborated with the South African Department of Health for two decades to support community-based, differentiated HIV and drug-resistant tuberculosis service delivery in the periurban township of Khayelitsha in the Western Cape, South Africa.<a href="#bib7">7</a>, <a href="#bib8">8</a> Khayelitsha now has one of the highest burdens of COVID-19 in the Western Cape, which in turn accounts for more than half South Africa's known cases.<a href="#bib9"><sup>9</sup></a></p> <p id="para440">Although routine activities have required adaptation during the COVID-19 pandemic, disruptions caused by the emergency response highlight potentially unnecessary health system interactions between people with tuberculosis and people with HIV, including facility-based counselling, long clinic waiting times to receive medications, and frequent follow-up, even for patients who are clinically well.</p> <p id="para450">This situation presents an opportunity for positive, long-term, systematic change to transform inefficient, paternalistic policies and practices. For example, clinical or counselling consultations over the telephone support patients (particularly those initiating treatment or re-engaging with services) while reducing contact for both the health-care providers and recipients. The need to reduce clinic attendance to shield the vulnerable and reduce exposure to health-care workers is also an opportunity to build home-based care, strengthen community and self-administered tuberculosis therapy, further decentralise medication pick-up, and extend ART and pre-exposure prophylaxis medication refills.</p> <p id="para460">Interventions developed specifically for COVID-19 could also enhance tuberculosis and HIV services. For example, community networks developed for COVID-19 screening could be repurposed to support tuberculosis and HIV: to expand tuberculosis screening and HIV self-testing, identify individuals who need additional support (eg, social grants), and link new cases or patients lost to follow-up to care. Stigma reduction campaigns for COVID-19 could also embrace positive messages about HIV and tuberculosis.</p> <p id="para470">Conversely, the COVID-19 pandemic has exposed systemic weaknesses, such as reduced medication supply and staff shortages, which will require dedicated health system strengthening and substantial investments to correct. South Africa has a 60â€ˆ000 strong cadre of community health workers but attempts to build on their community knowledge and access for contact tracing have revealed the poor integration of these workers into the health systemâ€"highlighted, for example, by their difficulty in accessing personal protective equipment and training. COVID-19 has also publicised the extreme economic vulnerability of individuals living with tuberculosis and HIV, and a commitment to mitigating the socioeconomic drivers and effects of both diseases must be maintained in the years to come.<a href="#bib10"><sup>10</sup></a> The <a href="#box1">panel</a> shows a summary of the potential collateral benefits from the COVID-19 pandemic to tuberculosis and HIV services. </p><div class="boxed-text" tagx="boxed-text" title="boxed-text"><span class="label" tagx="label" title="label">Panel</span> <div class="title" tagx="title" title="title">
Strategies to decrease the impact of COVID-19 on tuberculosis and HIV</div>  <p id="para10"><b>Existing interventions to scale up nationally or internationally</b></p> <p id="para20"><i>Tuberculosis</i></p> <p id="para30"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para40">Alternatives to directly observed therapy, such as self-administered therapy, improved treatment literacy</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para50">Community-based treatment initiation for all populations</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para60">Expanded use of all-oral, shorter regimens</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para70">Scaling up adapted, individualised counselling</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para80">Integrated tuberculosis and COVID-19 screening and testing</p> </li> </ul> <p /> <p id="para90"><i>HIV</i></p> <p id="para100"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para110">Differentiated models of care for stable HIV</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para120">Extended multimonth antiretroviral therapy (ART) refills (more than 6 months) for stable patients</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para130">Community-based initiation and delivery of ART</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para140">Integrated HIV and COVID-19 testing</p> </li> </ul> <p /> <p id="para150"><b>Adapted and expanded models</b></p> <p id="para160"><i>Tuberculosis</i></p> <p id="para170"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para180">Home-based care</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para190">Medical triage by telephone and individualised counselling and support (for substance use and for people who are not managing well on treatment)</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para200">Home-delivery of medication supplies to patients, as with other chronic diseases</p> </li> </ul> <p /> <p id="para210"><i>HIV</i></p> <p id="para220"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para230">Medical triage by telephone and individualised counselling and support, especially for those disengaged from care</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para240">Home delivery of chronic medication for stable patients</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para250">Longer refills (more than 2 months) for patients restarting treatment</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para260">Home-based care for patients with advanced HIV</p> </li> </ul> <p /> <p id="para270"><b>New opportunities for using COVID-19 interventions for tuberculosis and HIV</b></p> <p id="para280"><i>Tuberculosis</i></p> <p id="para290"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para300">Trained and paid community health workers to do active case finding, contact assessments, postexposure management, linkage to care for newly identified cases and those who have been lost to follow-up</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para310">Incorporate tuberculosis into COVID-19 stigma reduction messages</p> </li> </ul> <p /> <p id="para320"><i>HIV</i></p> <p id="para330"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para340">Trained and paid community health workers to support self-testing, provision of pre-exposure prophylaxis with nursing support, linkage to care for newly identified cases and those who have been lost to follow-up</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para350">Incorporate HIV into COVID-19 stigma reduction messages</p> </li> </ul> <p /> <p id="para360"><b>Investment and systematic changes needed</b></p> <p id="para370"> </p><ul> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para380">Address precarious socioeconomic circumstances</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para390">Strengthen health system to improve staffing and reduce stock-outs</p> </li> <li><span class="label" tagx="label" title="label">â€¢</span><p id="para400">Integrate tuberculosis, HIV, and chronic health services</p> </li> </ul> <p /> </div> <p /> <p id="para480">South Africa is valiantly fighting COVID-19; the national response to the pandemic has gained unprecedented political support and mobilised resources that would have been unimaginable a year ago. There has been a massive refocusing of the political agenda on health and the opportunityâ€"yet to be fully realisedâ€"to address the underlying social determinants that increase communities' vulnerability and result in differentiated mortality outcomes. The increased solidarity creates the opportunity for broader public participation and for addressing health as a public good, not just for COVID-19 but also for the other major health problems in the country, including HIV and tuberculosis. Though devastating, COVID-19 has offered the opportunity for true service delivery transformation that could result in lasting benefits when it comes to care for people with HIV and tuberculosis.</p> <p id="para490"> </p><div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/" /></div>  </div> <p /> </div> <div class="back" title="back"> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="bib1" /><span class="label" tagx="label" title="label">1</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Johns Hopkins University &amp;amp; Medicine</span></span><span class="mixed-article-title" title="mixed-article-title">COVID-19 dashboard</span><a href="https://coronavirus.jhu.edu/map.html">https://coronavirus.jhu.edu/map.html</a></span></li> <li tag="ref"><a name="bib2" /><span class="label" tagx="label" title="label">2</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Drain</span><span class="given-names" tagx="given-names" title="given-names">P</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Garrett</span><span class="given-names" tagx="given-names" title="given-names">N</span></span></span><span class="mixed-article-title" title="mixed-article-title">SARS-CoV-2 pandemic expanding in sub-Saharan Africa: considerations for Covid-19 in people living with HIV</span><span class="source" tagx="source" title="source">EClinicalMedicine</span><span class="year" tagx="year" title="year">2020</span><span class="comment">published online April 22.</span><span class="pub-id"><a href="https://dx.doi.org/10.1016/j.eclinm.2020.100342">10.1016/j.eclinm.2020.100342</a></span></span></li> <li tag="ref"><a name="bib3" /><span class="label" tagx="label" title="label">3</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Davies</span><span class="given-names" tagx="given-names" title="given-names">M-A</span></span></span><span class="mixed-article-title" title="mixed-article-title">Western Cape: COVID-19 and HIV / Tuberculosis. Presentation at the Bhekesisa Health Forum</span><a href="https://bhekisisa.org/multimedia/2020-06-09-standing-by-when-epidemics-collide-does-hiv-tb-cause-worse-covid-19/">https://bhekisisa.org/multimedia/2020-06-09-standing-by-when-epidemics-collide-does-hiv-tb-cause-worse-covid-19/</a><span class="year" tagx="year" title="year">June 9, 2020</span></span></li> <li tag="ref"><a name="bib4" /><span class="label" tagx="label" title="label">4</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Stop TB Partnership</span></span><span class="mixed-article-title" title="mixed-article-title">The potential impact of the COVID-19 response on tuberculosis in high-burden countries: a modelling analysis</span><a href="http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf">http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf</a><span class="year" tagx="year" title="year">May 20, 2020</span></span></li> <li tag="ref"><a name="bib5" /><span class="label" tagx="label" title="label">5</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jewell</span><span class="given-names" tagx="given-names" title="given-names">BL</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mudimu</span><span class="given-names" tagx="given-names" title="given-names">E</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stover</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kelly</span><span class="given-names" tagx="given-names" title="given-names">SL</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Phillips</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="mixed-article-title" title="mixed-article-title">Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models</span><span class="source" tagx="source" title="source">FigShare</span><span class="year" tagx="year" title="year">2020</span><span class="comment">published online May 11.</span><span class="pub-id"><a href="https://dx.doi.org/10.6084/M9.FIGSHARE.12279914.V1">10.6084/M9.FIGSHARE.12279914.V1</a></span><span class="comment">(preprint)</span></span></li> <li tag="ref"><a name="bib6" /><span class="label" tagx="label" title="label">6</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Reniers</span><span class="given-names" tagx="given-names" title="given-names">G</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Blom</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Calvert</span><span class="given-names" tagx="given-names" title="given-names">C</span></span></span><span class="mixed-article-title" title="mixed-article-title">Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study</span><span class="source" tagx="source" title="source">Lancet HIV</span><span class="volume" tagx="volume" title="volume">4</span><span class="year" tagx="year" title="year">2017</span><span class="fpage" tagx="fpage" title="fpage">e113</span><span class="lpage" tagx="lpage" title="lpage">e121</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27956187">27956187</a></span></span></li> <li tag="ref"><a name="bib7" /><span class="label" tagx="label" title="label">7</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cox</span><span class="given-names" tagx="given-names" title="given-names">H</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hughes</span><span class="given-names" tagx="given-names" title="given-names">J</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daniels</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="mixed-article-title" title="mixed-article-title">Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa</span><span class="source" tagx="source" title="source">Int J Tuberc Lung Dis</span><span class="volume" tagx="volume" title="volume">18</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">441</span><span class="lpage" tagx="lpage" title="lpage">448</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24670700">24670700</a></span></span></li> <li tag="ref"><a name="bib8" /><span class="label" tagx="label" title="label">8</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bemelmans</span><span class="given-names" tagx="given-names" title="given-names">M</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Baert</span><span class="given-names" tagx="given-names" title="given-names">S</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goemaere</span><span class="given-names" tagx="given-names" title="given-names">E</span></span></span><span class="mixed-article-title" title="mixed-article-title">Community-supported models of care for people on HIV treatment in sub-Saharan Africa</span><span class="source" tagx="source" title="source">Trop Med Int Health</span><span class="volume" tagx="volume" title="volume">19</span><span class="year" tagx="year" title="year">2014</span><span class="fpage" tagx="fpage" title="fpage">968</span><span class="lpage" tagx="lpage" title="lpage">977</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/24889337">24889337</a></span></span></li> <li tag="ref"><a name="bib9" /><span class="label" tagx="label" title="label">9</span><span class="element-citation'"><span class="person-group'"><span class="collab'">collab: Department of Health, South Africa</span></span><span class="mixed-article-title" title="mixed-article-title">Update on COVID-19</span><a href="https://sacoronavirus.co.za/2020/06/17/update-on-covid-19-17th-june-2020/">https://sacoronavirus.co.za/2020/06/17/update-on-covid-19-17th-june-2020/</a><span class="year" tagx="year" title="year">June 17, 2020</span></span></li> <li tag="ref"><a name="bib10" /><span class="label" tagx="label" title="label">10</span><span class="element-citation'"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dheda</span><span class="given-names" tagx="given-names" title="given-names">K</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gumbo</span><span class="given-names" tagx="given-names" title="given-names">T</span></span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maartens</span><span class="given-names" tagx="given-names" title="given-names">G</span></span></span><span class="mixed-article-title" title="mixed-article-title">The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis</span><span class="source" tagx="source" title="source">Lancet Respir Med</span><span class="volume" tagx="volume" title="volume">7</span><span class="year" tagx="year" title="year">2019</span><span class="fpage" tagx="fpage" title="fpage">820</span><span class="lpage" tagx="lpage" title="lpage">826</span><span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/31486393">31486393</a></span></span></li> </ul> </div> <div class="ack" title="ack"> <p>We declare no competing interests.</p> </div> </div>  </body></html>